(76 days)
No
The summary does not mention AI, ML, or related terms, and the device description focuses on mechanical pressure for treatment.
Yes
The device is intended to treat moderate to severe nonsynostotic cranial deformation and moderate to severe cranial deformities, which is a therapeutic purpose.
No
The device description clearly states it is a "cranial orthosis intended to treat positional plagiocephaly," and its purpose is to "apply a mild pressure to the prominent regions of an infant's cranium and to improve cranial symmetry, proportion, and/or shape." It is described as a treatment device, not one used for diagnosis.
No
The device description explicitly states it is a "cranial orthosis" and describes its function as applying "mild pressure," indicating a physical, hardware-based device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The DOC Band 3D is a cranial orthosis that is applied externally to an infant's head to reshape it. It does not involve testing samples from the body.
- Intended Use: The intended use is to treat cranial deformities, not to diagnose a condition through laboratory testing.
- Device Description: The description focuses on the physical properties and application of the band, not on analytical or diagnostic procedures.
Therefore, the DOC Band 3D falls under the category of a medical device used for treatment, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The DOC Band 3D (band) is a medical device known generically as a cranial orthosis. A cranial orthosis is used to treat a medical condition known as deformational plagiocephaly brachycephaly (DPB).
The DOC Band is indicated for use on infants from three to eighteen months of age with moderate to severe nonsynostotic cranial deformation, infants with plagiocephalic-, and scaphocephalic-, and scaphocephalic-shaped heads, or a combination thereof.
The DOC Band 3D is also indicated for adjunctive use for infants from three to eighteen months of age whose synostosis has been surgically corrected, but who still have moderate to severe cranial deformities including plagiocephalic-. brachycephalic-, and scaphocephalic-shaped heads, or a combination thereof.
Product codes
OAN
Device Description
The DOC Band 3D is a cranial orthosis intended to treat positional plagiocephaly in infants from 3 to 18 months of age. The band is intended to apply a mild pressure to the prominent regions of an infant's cranium and to improve cranial symmetry, proportion, and/or shape.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Cranium
Indicated Patient Age Range
three to eighteen months of age
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench testing has demonstrated that the device's mechanical properties meet or exceed those of the predicate devices. The clinical performance of the DOC Band 3D is expected to be comparable to the predicate devices in the treatment of deformational plagiocephaly.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5970 Cranial orthosis.
(a)
Identification. A cranial orthosis is a device that is intended for medical purposes to apply pressure to prominent regions of an infant's cranium in order to improve cranial symmetry and/or shape in infants from 3 to 18 months of age, with moderate to severe nonsynostotic positional plagiocephaly, including infants with plagiocephalic-, brachycephalic-, and scaphocephalic-shaped heads.(b)
Classification. Class II (special controls) (prescription use in accordance with § 801.109 of this chapter, biocompatibility testing, and labeling (contraindications, warnings, precautions, adverse events, instructions for physicians and parents)).
0
March 17, 2025
Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is a symbol representing the Department of Health & Human Services-USA. To the right of the symbol, there is a blue square with the letters 'FDA' in white. Next to the blue square, the words 'U.S. FOOD & DRUG' are written in blue, with 'ADMINISTRATION' written in a smaller font size below.
Cranial Technologies, Inc. Jeff Riggs Quality Manager 1405 W Auto Dr, Floor 2 Tempe, Arizona 85284
Re: K244056
Trade/Device Name: DOC Band 3D Regulation Number: 21 CFR 882.5970 Regulation Name: Cranial Orthosis Regulatory Class: Class II Product Code: OAN Dated: December 31, 2024 Received: December 31, 2024
Dear Jeff Riggs:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (OS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rue"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
2
Sincerely,
Digitally signed by Adam D. Adam D. Pierce -S Date: 2025.03.17 Pierce -S 15:50:01 -04'00'
Adam D. Pierce, Ph.D. Assistant Director DHT5A: Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K244056
Device Name DOC Band 3D
Indications for Use (Describe)
The DOC Band is indicated for use on infants from three to eighteen months of age with moderate to severe nonsynostotic cranial deformation, infants with plagiocephalic-, and scaphocephalic-, and scaphocephalic-shaped heads, or a combination thereof.
The DOC Band 3D is also indicated for adjunctive use for infants from three to eighten months of age whose synostosis has been surgically corrected, but who still have moderate to severe cranial deformities including plagiocephalic-. brachycephalic-, and scaphocephalic-shaped heads, or a combination thereof.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) | |
|---|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) Summary
Date: 03/17/2025
Applicant: Cranial Technologies, Inc.
Contact Person: Jeff Riggs
Phone: 480-403-6350
Address: 6511 W Frye Rd, Suite 3
Chandler, AZ 85226
Trade Name: DOC Band 3D
Common Name: Cranial Orthosis
Device Classification: Class II
Product Code: OAN
Requlation Number: 21 CFR 882.5970
Device Description: The DOC Band 3D is a cranial orthosis intended to treat positional plagiocephaly in infants from 3 to 18 months of age. The band is intended to apply a mild pressure to the prominent regions of an infant's cranium and to improve cranial symmetry, proportion, and/or shape.
Theory of Operation: The DOC Band 3D works by applying a mild holding pressure in regions where the head is already too prominent, while encouraging growth in the adjacent flattened regions. In this manner, the band is used to treat not only craniofacial asymmetry, but also proportionality (length to width ratio) of the head. The band is used from three to eighteen months of age because this is the period of rapid brain growth. After two years of age, skull growth stops, and any remaining growth of the cranium is primarily from thickening and hardening of the cranial bones,
Predicate Device(s):
Substantial Equivalence: The DOC Band 3D is substantially equivalent to the predicate devices. The primary difference is the manufacturing process: the DOC Band 3D utilizes 3D printing technology to fabricate the outer shell, while the predicate devices used vacuum forming. This change allows for greater precision and customization without affecting the device's intended use, safety, or effectiveness.
5
Intended Use: The DOC Band 3D (band) is a medical device known generically as a cranial orthosis. A cranial orthosis is used to treat a medical condition known as deformational plagiocephaly brachycephaly (DPB).
Indications for Use: The DOC Band is indicated for use on infants from three to eighteen months of age with moderate to severe non-synostotic cranial deformation, including infants with plagiocephalic-, brachycephalic-, and scaphocephalic-shaped heads, or a combination thereof.
The DOC Band 3D is also indicated for adjunctive use for infants from three to eighteen months of age whose synostosis has been surgically corrected, but who still have moderate to severe cranial deformities including plagiocephalic-, brachycephalic-, and scaphocephalic/dolicocephalic- shaped heads, or a combination thereof.
Contraindications for Use: The DOC Band 3D is contraindicated for use on infants with craniosynostosis or hydrocephalus.
Summary of Safety and Effectiveness: The DOC Band 3D is made from biocompatible materials that have undergone ISO 10993 testing to ensure safety. Bench testing has demonstrated that the device's mechanical properties meet or exceed those of the predicate devices. The clinical performance of the DOC Band 3D is expected to be comparable to the predicate devices in the treatment of deformational plagiocephaly.
| Feature/Parameter | Predicate Device (DOC Band -
K964992, K141012, K042385) | 3D Printed Cranial Remodeling
Orthosis (DOC Band 3D) |
|---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | The DOC Band (band) is a
medical device known
generically as a cranial
orthosis. A cranial orthosis is
used to treat a medical
condition known as
deformational plagiocephaly
brachycephaly (DPB). | The DOC Band 3D (band) is a
medical device known
generically as a cranial
orthosis. A cranial orthosis is
used to treat a medical
condition known as
deformational plagiocephaly
brachycephaly (DPB). |
| Indications for Use | The DOC Band is indicated for
use on infants from three to
eighteen months of age with
moderate to severe non-
synostotic cranial deformation,
including infants with
plagiocephalic-,
brachycephalic-, and | The DOC Band 3D is indicated
for use on infants from three to
eighteen months of age with
moderate to severe non-
synostotic cranial deformation,
including infants with
plagiocephalic-,
brachycephalic-, and |
| Feature/Parameter | Predicate Device (DOC Band -
K964992, K141012, K042385) | 3D Printed Cranial Remodeling
Orthosis (DOC Band 3D) |
| | scaphocephalic-shaped heads,
or a combination thereof. | scaphocephalic-shaped heads,
or a combination thereof. |
| | The DOC Band PostOp is also
indicated for adjunctive use for
infants from three to eighteen
months of age whose
synostosis has been surgically
corrected, but who still have
moderate to severe cranial
deformities including
plagiocephalic-,
brachycephalic-, and
scaphocephalic/dolicocephalic-
shaped heads. | The DOC Band 3D is also
indicated for adjunctive use for
infants from three to eighteen
months of age whose
synostosis has been surgically
corrected, but who still have
moderate to severe cranial
deformities including
plagiocephalic-,
brachycephalic-, and
scaphocephalic/dolicocephalic-
shaped heads. |
| Materials: Outer
Shell | Semi-rigid copolymer
(polypropylene-ethylene) | Semi-rigid polyamide (3D
printed) |
| Materials: Inner
Layer | Lightweight polyethylene foam | Lightweight polyethylene foam |
| Manufacturing
Process | Vacuum forming over a milled
plaster model | 3D printing |
| Biocompatibility | Biocompatible materials tested | Biocompatible materials tested |
| Bench Testing | Mechanical properties tested | Mechanical properties tested;
meets or exceeds predicate
performance |
| Sizing | Customized for each patient | Customized for each patient |
| Fitting and
Adjustment | Custom-fit by clinician,
adjustments as needed | Custom-fit by clinician,
adjustments as needed |
Comparison of DOC Band 3D to Predicate Devices
6
7
Test Summary of Non-Clinical Data
To ensure substantial equivalence of their mechanical forces, the predicate DOC Band and proposed DOC Band 3D both underwent mechanical testing of their shear, flexural, stiffness, fatigue and bond strength. Senior clinicians evaluated the proposed device against the predicate device to confirm equivalent donning and doffing procedures, trims and adjustment procedures, demonstrating substantial equivalence in the fit and treatment protocols. The new material in the proposed device (as compared to the predicate) is the outer shell. It is a polyamide 12 resin, which was tested per ISO 10993 for cytotoxicity, irritation and sensitization, passing all tests per standards.
Conclusion: The DOC Band 3D is substantially equivalent to the predicate device.